Immuneering Corporation
IMRX
$5.58
-$0.3351-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.43M | -15.05M | -18.05M | -14.60M | -14.08M |
| Total Depreciation and Amortization | 91.80K | 92.60K | 93.40K | 96.30K | 97.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.61M | 1.78M | 1.76M | 1.69M | 1.73M |
| Change in Net Operating Assets | 3.29M | -902.50K | 1.69M | -657.60K | 724.50K |
| Cash from Operations | -9.45M | -14.08M | -14.51M | -13.47M | -11.53M |
| Capital Expenditure | -2.10K | -8.90K | -9.40K | -5.30K | -32.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 5.50M | -5.41M | 5.00M |
| Cash from Investing | -2.10K | -8.90K | 5.49M | -5.42M | 4.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.10K | 13.81M | 86.40K | 4.36M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.00K | -- | -127.40K | -- | -- |
| Cash from Financing | -62.00K | 13.81M | -41.00K | 4.36M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.51M | -279.00K | -9.06M | -14.52M | -6.56M |